TransDigm price target raised to $1,575 from $1,550 at Morgan Stanley

Morgan Stanley analyst Kristine Liwag raised the firm’s price target on TransDigm to $1,575 from $1,550 and keeps an Overweight rating on the shares. TransDigm continues to showcase strong execution and “surprise to the upside on both growth and margins,” says the analyst, who argues that recently completed deals provide additional levers for upside.